• Info
  • Insider Ownership

Insider Trading & Ownership of Sharon Tetlow

Location
South San Francisco, CA
Signature
/s/ Jun Yoon, Attorney-in-Fact
All Insider Reports
All Insider Reports

Follow Filing Activity

Follow Sharon Tetlow and return when a new Insider Trading filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.

Sign up to save research and follow filings

Sponsored

Quick Takeaways

  • Sharon Tetlow has 3 issuer positions tracked on this page.
  • Estimated disclosed ownership value is not available.
  • Recent insider filing activity is available below.

What Changed

  • Largest disclosed position: CATALYST BIOSCIENCES, INC. ().
  • Past-year value change for that position: .

Why This Matters

  • This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
  • You can cross-check role, issuer, and filing chronology directly against the SEC source.

Source Evidence

Filed on Form 4

Insider ownership context is sourced from SEC Forms 3, 4, and 5.

See Original Filing

Ownership of Sharon Tetlow

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GYRE CATALYST BIOSCIENCES, INC. Director 09 Jun 2021
DICE DICE Therapeutics, Inc. Director 09 Aug 2023
GPCR Structure Therapeutics Inc. Director 23 Jun 2025

Insider Transactions Reported by Sharon Tetlow:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored